Yaras Brandon
Reporting owner on Forms 3, 4 and 5, CIK 2156611.
Yaras Brandon reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-01.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| aTYR PHARMA INC CIK 1339970 | officer (Chief Financial Officer) | 2 | 2026-10-01 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| aTYR PHARMA INC Employee Stock Option (right to buy), derivative | 2026-10-01 | A granted | +410,000 | $0 | 410,000 | Form 4 |
| aTYR PHARMA INC Employee Stock Option (right to buy), derivative, holding | Form 3 | |||||
| aTYR PHARMA INC Employee Stock Option (right to buy), derivative, holding | Form 3 | |||||
| aTYR PHARMA INC Employee Stock Option (right to buy), derivative, holding | Form 3 | |||||
| aTYR PHARMA INC Employee Stock Option (right to buy), derivative, holding | Form 3 | |||||
| aTYR PHARMA INC Employee Restricted Stock Unit, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002156611-26-000010 | aTYR PHARMA INC | 2026-10-01 | ||
| Form 3 0002156611-26-000008 | aTYR PHARMA INC | 2026-10-01 |